Evidence of Copper Nanoparticles and Poly I:C Modulating Cas9 Interaction and Cleavage of COR (Conserved Omicron RNA)

Author:

Karrer Lindy G.1,Mathew Elza Neelima2ORCID,Nava-Chavez Juliet2,Bhatti Abeera2ORCID,Delong Robert K.3

Affiliation:

1. Division of Biology, Kansas State University, Manhattan, KS 66506, USA

2. Department of Anatomy and Physiology, Kansas State University, Manhattan, KS 66506, USA

3. Landmark Bio, Innovation Development Laboratory, Watertown, MA 02472, USA

Abstract

Conserved omicron RNA (COR) is a 40 base long 99.9% conserved sequence in SARS-CoV-2 Omicron variant, predicted to form a stable stem loop, the targeted cleavage of which can be an ideal next step in controlling the spread of variants. The Cas9 enzyme has been traditionally utilized for gene editing and DNA cleavage. Previously Cas9 has been shown to be capable of RNA editing under certain conditions. Here we investigated the ability of Cas9 to bind to single-stranded conserved omicron RNA (COR) and examined the effect of copper nanoparticles (Cu NPs) and/or polyinosinic-polycytidilic acid (poly I:C) on the RNA cleavage ability of Cas9. The interaction of the Cas9 enzyme and COR with Cu NPs was shown by dynamic light scattering (DLS) and zeta potential measurements and was confirmed by two-dimensional fluorescence difference spectroscopy (2-D FDS). The interaction with and enhanced cleavage of COR by Cas9 in the presence of Cu NPs and poly I:C was shown by agarose gel electrophoresis. These data suggest that Cas9-mediated RNA cleavage may be potentiated at the nanoscale level in the presence of nanoparticles and a secondary RNA component. Further explorations in vitro and in vivo may contribute to the development of a better cellular delivery platform for Cas9.

Funder

Cystic Fibrosis Foundation

Publisher

MDPI AG

Subject

Bioengineering

Reference50 articles.

1. CDC (2023, January 31). “Coronavirus Disease 2019 (COVID-19),” Centers for Disease Control and Prevention. 11 February 2020, Available online: https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-classifications.html.

2. Emergence of SARS-CoV-2 New Variants and Their Clinical Significance;Singh;Can. J. Infect. Dis. Med. Microbiol.,2022

3. CDC (2023, February 23). “Understanding How COVID-19 Vaccines Work,” Centers for Disease Control and Prevention. 3 February 2023, Available online: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/how-they-work.html.

4. Huber, H.F., Jaberi-Douraki, M., DeVader, S., Aparicio-Lopez, C., Nava-Chavez, J., Xu, X., Gedara, N.I.M., Gaudreault, N.N., and Delong, R.K. (2021). Targeting SARS-CoV-2 Variants with Nucleic Acid Therapeutic Nanoparticle Conjugates. Pharmaceuticals, 14.

5. Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product;Ishino;J. Bacteriol.,1987

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3